Facet Wedge Post Market Study
A Multi-centre, Prospective, Single-arm Post Market Clinical Follow up Study (PMCF) of the FACET WEDGE Spinal System to Assess Outcomes in Subjects With Chronic Low Back Pain Due to Degenerative Disc Disease (DDD), Facet Joint Disease and/or Pseudo Arthrosis Post Anterior Instrumentation
1 other identifier
observational
50
2 countries
3
Brief Summary
A Multi-centre, Prospective, single-arm post market clinical follow up study (PMCF) of the FACET WEDGETM spinal system to assess outcomes in subjects with chronic low back pain due to Degenerative Disc Disease (DDD), facet joint disease and/or pseudo arthrosis post anterior instrumentation. The objective of this study is to assess outcomes following implantation of the FACET WEDGE spinal system when used to provide fixation of lumbar motion segments. The primary objective of this study is to determine the rate of re-operations at the index level(s). The secondary objectives of this study are to confirm the safety and performance of the device and to collect patient reported outcome data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2014
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 28, 2014
CompletedFirst Posted
Study publicly available on registry
July 30, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2018
CompletedOctober 19, 2018
October 1, 2018
4.3 years
July 28, 2014
October 18, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
reoperation rate at the index level(s)
at two years
Secondary Outcomes (4)
the radiographic range of motion (ROM) at the index levels
Pre-treatment, 6 months, 12 months, 24 months
patient (back and leg) pain reported on a Numeric Rating Scale (NRS)
pre-treatment, prior to D/C, 6 weeks, 6 months, 12 months, 24 months.
functional success based on results from the Oswestry Disability Index (ODI)
Pre-treatment, 6 weeks, 6 months, 12 months, 24 months
Adverse events
Throughout the study
Study Arms (1)
FACET WEDGE spinal system
The FACET WEDGE spinal system provides additional stability to a spinal segment to enhance fusion conditions.
Interventions
Eligibility Criteria
The cases in the cohort are selected from patients treated in hospitals.
You may qualify if:
- Subjects diagnosed with at least one of the following:
- Degenerative Disc Disease (DDD);
- Degenerative facet joint disease (isolated facet based symptomatic back pain);
- Pseudoarthrosis post anterior instrumentation;
- Subjects who are a fusion candidate for single or multiple levels fusion between L1-S1;
- Subjects, who, in the opinion of the Investigator, are able to understand this clinical investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
You may not qualify if:
- Segmental instability of the index level in case of planned stand-alone FACET WEDGE usage;
- Unilateral application , except in combination with pediclescrew fixation on the contralateral side;
- Compromised facets due to decompression techniques;
- Spondylolisthesis;
- Fracture or other instabilities of the posterior elements;
- Tumor;
- Acute or chronic systemic or localized spinal infections;
- Nursing mothers or women who are pregnant or plan to become pregnant during the time of the study;
- Subjects aged below 18 years;
- Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this clinical investigation;
- Intraoperative decision to use implants other than the device under investigation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Synthes GmbHlead
Study Sites (3)
BG Unfallklinik
Frankfurt am Main, 60439, Germany
Schon Klinik Munchen
München, 81547, Germany
UVN
Ružomberok, Slovakia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Kandziora, PhD
Berufsgenossenschaftliche Unfallklinik, Frankfurt am Main, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2014
First Posted
July 30, 2014
Study Start
May 1, 2014
Primary Completion
August 31, 2018
Study Completion
August 31, 2018
Last Updated
October 19, 2018
Record last verified: 2018-10